LNCSRLR
gene geneOn this page
Also known as lncRNA-SRLR
Summary
LNCSRLR (lncRNA sorafenib resistance in renal cell carcinoma associated, HGNC:52753) is a long non-coding RNA gene on chromosome 3q24.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52753 |
| Approved symbol | LNCSRLR |
| Name | lncRNA sorafenib resistance in renal cell carcinoma associated |
| Location | 3q24 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | lncRNA-SRLR |
| Ensembl gene | ENSG00000240032 |
| Ensembl biotype | lncRNA |
| Entrez | 109729161 |
| RNAcentral | URS0000074712 — lncRNA, 709 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 lncRNA
ENST00000490375
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000490375 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001890730 | 146068819 | 146069185 |
| ENSE00001944293 | 146066344 | 146066685 |
Expression profiles
Bgee: expression breadth ubiquitous, 122 present calls, max score 85.34.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0695 / max 13.9922, expressed in 21 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 44887 | 0.0695 | 21 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.34 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.50 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.00 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.26 | gold quality |
| ventricular zone | UBERON:0003053 | 64.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 64.11 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 63.78 | gold quality |
| stromal cell of endometrium | CL:0002255 | 63.08 | gold quality |
| ascending aorta | UBERON:0001496 | 61.70 | gold quality |
| tibial artery | UBERON:0007610 | 61.18 | gold quality |
| popliteal artery | UBERON:0002250 | 61.12 | gold quality |
| thoracic aorta | UBERON:0001515 | 61.10 | gold quality |
| liver | UBERON:0002107 | 60.72 | gold quality |
| corpus callosum | UBERON:0002336 | 60.29 | gold quality |
| gall bladder | UBERON:0002110 | 59.51 | gold quality |
| pancreas | UBERON:0001264 | 58.93 | gold quality |
| myometrium | UBERON:0001296 | 57.35 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 56.99 | gold quality |
| left coronary artery | UBERON:0001626 | 56.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 56.71 | gold quality |
| urinary bladder | UBERON:0001255 | 56.51 | gold quality |
| vermiform appendix | UBERON:0001154 | 56.46 | gold quality |
| mucosa of stomach | UBERON:0001199 | 56.32 | gold quality |
| omental fat pad | UBERON:0010414 | 56.28 | gold quality |
| right atrium auricular region | UBERON:0006631 | 56.07 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 56.02 | gold quality |
| thyroid gland | UBERON:0002046 | 55.92 | gold quality |
| kidney | UBERON:0002113 | 55.80 | gold quality |
| cortex of kidney | UBERON:0001225 | 55.78 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 55.71 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Upregulation of the lncRNA SRLR in polycystic ovary syndrome regulates cell apoptosis and IL-6 expression. (PMID:31999854)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.